Lineage Cell Therapeutics (LCTX) Earnings Date, Estimates & Call Transcripts $1.03 +0.01 (+0.98%) Closing price 07/11/2025 04:10 PM EasternExtended Trading$1.02 -0.01 (-0.49%) As of 07/11/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics Earnings Summary Lineage Cell Therapeutics issued Q2 2024 earnings on August 8, 2024, reporting an EPS of -$0.03, which beat analysts' consensus estimates of -$0.04 by $0.01. Quarterly revenue was reported to be $1.41 million, above analyst estimates of $1.28 million. With a trailing EPS of -$0.12, Lineage Cell Therapeutics' earnings are expected to grow next year, from ($0.12) to ($0.09) per share. Upcoming Q3 Earnings DateAug. 6After Market ClosesEstimatedConsensus EPS (Aug. 8) -$0.04 Actual EPS (Aug. 8) -$0.03 Beat By $0.01 Actual Revenue (Aug. 8) $1.41MQ2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)LCTX Upcoming EarningsLineage Cell Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Lineage Cell Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lineage Cell Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLCTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LCTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lineage Cell Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.03-$0.01-$0.02Q2 20252-$0.03-$0.02-$0.03Q3 20251-$0.02-$0.02-$0.02Q4 20252-$0.03-$0.02-$0.03 Lineage Cell Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------8/8/2024--$0.04-$0.03+$0.01-$0.03$1.28M$1.41M5/9/2024Q1 2024-$0.04-$0.04--$0.04$2.22M$1.44M3/7/2024Q4 2023-$0.07-$0.03+$0.04-$0.03$4.74M$2.09M11/9/2023Q3 2023-$0.04-$0.04--$0.04$3.30M$1.25M8/10/2023Q2 2023-$0.04-$0.03+$0.01-$0.03$2.65M$3.23M Lineage Cell Therapeutics Earnings - Frequently Asked Questions When is Lineage Cell Therapeutics' earnings date? Lineage Cell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on LCTX's earnings history. Did Lineage Cell Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.04) by $0.01. Learn more on analysts' earnings estimate vs. LCTX's actual earnings. How can I listen to Lineage Cell Therapeutics' earnings conference call? The conference call for Lineage Cell Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Lineage Cell Therapeutics' conference call transcript? The conference call transcript for Lineage Cell Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Lineage Cell Therapeutics generate each year? Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded annual revenue of $9.50 million. How much profit does Lineage Cell Therapeutics generate each year? Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) has a recorded net income of -$18.61 million. LCTX has generated -$0.12 earnings per share over the last four quarters. What is Lineage Cell Therapeutics' EPS forecast for next year? Lineage Cell Therapeutics' earnings are expected to grow from ($0.12) per share to ($0.09) per share in the next year. More Earnings Resources from MarketBeat Related Companies AVXL Earnings ORIC Earnings LENZ Earnings ZYME Earnings RCUS Earnings AVDL Earnings COGT Earnings OCS Earnings CMRX Earnings CDMO Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NYSEAMERICAN:LCTX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
